4
Changes in Ownership
Keros Therapeutics, Inc. Filed Acc 0001209191-20-023990
Options or other derivatives
- Chief Financial Officer acquired 152,052 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
Regnante Keith · Chief Financial Officer
Table II: Derivative
2 lines| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2020-04-07 | Grant or award : show line 1 in the form Employee Stock Option (right to buy) | +18,430 | 18,430 | D |
| 2020-04-07 | Grant or award : show line 2 in the form Employee Stock Option (right to buy) | +133,622 | 133,622 | D |
Loading xslF345X03/doc4.xml…